All terms in MESH
| Label | Id | Description |
|---|---|---|
| 16p11.2 Deletion Syndrome | C579850 | |
| 2-hydroxycyclohexanecarboxyl Coenzyme A dehdrogenase | C408970 | |
| LIP2 protein, Yarrowia lipolytica | C408971 | |
| fozivudine tidoxil | C408972 | |
| DltD protein, bacteria | C408973 | |
| Alu-binding protein, 68 kDa, human | C408965 | |
| N-butyl-N-methyl-11-(3'-hydroxy-21'-17'-carbolactone-19'-nor-17' -pregna-1',3',5'(10')-trien-7'-yl)-undecanamide | C408966 | |
| tetrazolo(1,5-a)(1,4)benzodiazepine | C408967 | |
| triazolo(4,3-d)benzodiazepine | C408968 | |
| SK 1899 | C408969 | |
| Mental Retardation, Microcephaly, Growth Retardation, Joint Contractures, and Facial Dysmorphism | C565246 | |
| Thyroid Carcinoma, Nonmedullary 1 | C565247 | |
| Mental Retardation, Short Stature, Facial Anomalies, and Joint Dislocations | C565248 | |
| Atrioventricular Septal Defect, Partial, with Heterotaxy Syndrome | C565249 | |
| Paget Disease Of Bone 4 | C565240 | |
| 3b-Hydroxysteroid Dehydrogenase Deficiency | C579862 | |
| NA-STAR 1,2-dioxetane | C408962 | |
| eugenol-4-allyl-2-methoxyphenol | C408963 | |
| 3-Methylglutaconic Aciduria | C579867 | |
| quimethazin | C408964 |